Calcium-Based Antimicrobial Peptide Compounds Attenuate DNFB-Induced Atopic Dermatitis-Like Skin Lesions via Th-Cells in BALB/c Mice
Open Access
- 26 September 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11371
Abstract
Atopic dermatitis (AD) is a chronic and recurrent inflammatory skin disease, characterized by severe itching and recurrent skin lesions. We hypothesized that a novel treatment involving calcium-based antimicrobial peptide compounds (CAPCS), a combination of natural calcium extracted from marine shellfish, and a variety of antimicrobial peptides, may be beneficial for AD. We established a dinitrofluorobenzene (DNFB)-induced AD model in BALB/c mice to test our hypothesis. We observed mouse behavior and conducted histopathological and immunohistochemical analyses on skin lesions before and after CAPCS treatment. We also characterized the changes in the levels of cytokines, inflammatory mediators, and Toll-like receptors (TLRs) in plasma and skin lesions. The results showed that (i) topical application of CAPCS ameliorated AD-like skin lesions and reduced scratching behavior in BALB/c mice; (ii) CAPCS suppressed infiltration of inflammatory cells and inhibited the expression of inflammatory cytokines in AD-like skin lesions; (iii) CAPCS reduced plasma levels of inflammatory cytokines; and (iv) CAPCS inhibited TLR2 and TLR4 protein expression in skin lesions. Topical application of CAPCS exhibits a therapeutic effect on AD by inhibiting inflammatory immune responses via recruiting helper T cells and engaging the TLR2 and TLR4 signaling pathways. Therefore, CAPCS may be useful for the treatment of AD.Keywords
Funding Information
- Sichuan University-Zigong Special Fund (2021CDZG-21, 2021-YF05-01427-SN, 2020YFS0195, HX-H1911217)
- Foundation Chengdu Municipal Science and Technology Bureau (2021CDZG-21, 2021-YF05-01427-SN, 2020YFS0195, HX-H1911217)
- Science & Technology Department of Sichuan Province (2021CDZG-21, 2021-YF05-01427-SN, 2020YFS0195, HX-H1911217)
- West China Hospital scientific research project (2021CDZG-21, 2021-YF05-01427-SN, 2020YFS0195, HX-H1911217)
This publication has 28 references indexed in Scilit:
- Atopic dermatitisThe Lancet, 2016
- The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarizationJournal of Allergy and Clinical Immunology, 2015
- In vivo expression of antimicrobial peptides in atopic dermatitisExperimental Dermatology, 2015
- Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbiditiesAllergy, 2015
- Molecular Biology of Atopic DermatitisClinical Reviews in Allergy & Immunology, 2014
- Activation of Epidermal Toll-Like Receptor 2 Enhances Tight Junction Function: Implications for Atopic Dermatitis and Skin Barrier RepairJournal of Investigative Dermatology, 2013
- The Role of T‐Regulatory Cells and Toll‐Like Receptors 2 and 4 In Atopic DermatitisScandinavian Journal of Immunology, 2012
- Genome-wide analysis of gene expression by crotonaldehyde in human umbilical vein endothelial cellsMolecular & Cellular Toxicology, 2011
- IL-25 in Atopic Dermatitis: A Possible Link between Inflammation and Skin Barrier Dysfunction?Journal of Investigative Dermatology, 2011
- Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infectionsBiomaterials, 2010